May Guo

Company: Areterna

Job title: Chief Commercial Officer

Seminars:

Vinylphosphonic Acid Modified Cap Analogs and Their Performance in mRNA Vaccines 2:30 pm

Development of Vinylphosphonic Acid Modified Cap GAG (CAP5011) and GAU (CAP1811) Synthesis of mRNA using CAP5011 and CAP1811, and encapsulation in LNP Testing of mRNA capped with CAP5011 and CAP1811, including protein expression, vaccine induced immune response in vivo and mRNA safety in NHP.Read more

day: Day 1 Track 2 PM